vTv Therapeutics (VTVT) Interest Expenses (2014 - 2025)

vTv Therapeutics has disclosed Interest Expenses across 11 years of filings, most recently posting $1000.0 for Q4 2025.

• Interest Expenses for Q4 2025 came in at $1000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $6000.0 (changed N/A YoY), and the FY2025 annual result was $6000.0, changed N/A from the prior year.
• Interest Expenses came in at $1000.0 for Q4 2025 at vTv Therapeutics, down from $5000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $8000.0 in Q3 2022 to a low of $1000.0 in Q1 2022.
• The 4-year median for Interest Expenses is $5500.0 (2021), against an average of $4600.0.
• Across the five-year window, Interest Expenses sank 97.45% in 2021 and jumped 33.33% in 2022, its largest moves.
• vTv Therapeutics' Interest Expenses stood at $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then grew by 16.67% to $7000.0 in 2023, then sank by 85.71% to $1000.0 in 2025.
• The last three Interest Expenses figures came in at $1000.0 (Q4 2025), $5000.0 (Q3 2025), and $7000.0 (Q4 2023), per Business Quant data.